Expression cloning is a powerful technique to identify specific genes encoding a protein of interest with unknown sequence. It relies on the biological expression and activity of a cDNA in a host system such as bacteria, yeast, or mammalian cells (1, 2) . In mammalian cells, a cDNA library can be stably transduced using retroviral expression and screened for the protein of interest. The cDNA is then rescued by PCR (3) . Alternately, a cDNA library can be transiently transfected into mammalian cells and screened for the protein of interest, followed by isolation of cDNA from clones expressing the protein of interest using Hirt's method, which involves selective precipitation of transiently transfected DNA in mammalian cells (4) . The methodology of screening clones expressing a protein of interest was drastically improved with the introduction of an immunological affinity step, where cDNA clones expressing cell surface antigen are physically selected by adhesion over antibody coated dishes (5) (6) (7) (8) . Although panning protocols have been widely used, irrelevant cells that contaminate the population of true transfectants reduce the cloning efficiency (9-10). Fluorescent-associated cell sorting (FACS) can further improve expression cloning techniques by physically isolating individually labeled cells based on multiparameter selection criterion. High-speed sorting (usually 10 4 -10 5 cells/min) can greatly increase the number of cells screened and reduce the time involved (11) (12) (13) . Both panning and FACS protocols have relied on surface expression of the protein, which can be a limiting factor for isolating genes encoding cytoplasmic proteins.
For the first time, we show that FACS can be used to screen a cDNA library to isolate clones expressing intracellular proteins. c-erbB2 protein is overexpressed in cancer cells and has an extracellular transmembrane and intracellular domain. We used a monoclonal antibody (MAb) against the intracellular domain of c-erbB2 protein to screen a cDNA library from HT29 cells (colon carcinoma cell line; from ATCC, Manassas, VA, USA) and enriched the clone of interest using FACS. The complete cDNA library was transfected into Cos7 cells, which were then fixed, permeabilized, and immunostained with anti-c-erbB2 MAb, followed by fluorescently labeled secondary antibody. Using FACS, the brightest cells were collected, and episomal DNA was extracted, amplified in bacterial cells, transfected into Cos7 cells, and rescreened. The clone of interest showed nearly 10-fold enrichment by the second round of sorting. Subsequent screening in the third round resulted in the isolation of a cDNA clone encoding cytoplasmic domain of c-erbB2 protein (adapted from Reference 14) .
The exact protocol used in this study was as follows. The messenger RNA (mRNA) from the HT29 cells was isolated using oligo(dT) primers (Invitrogen, Carlsbad, CA, USA). The cDNA was custom synthesized by Stratagene (La Jolla, CA, USA) and cloned into the pBK-CMV ZAP-Express ® vector (Stratagene) using EcoRI and XhoI adapters (15) . The average size of the insert DNA was 2 kb. The cDNA library was transfected into Cos7 cells (from ATCC), plated on tissue culturetreated Falcon ® 10-cm dishes. Cells were approximately 60% confluent at the time of transfection. Ten micrograms DNA and 20 µL FuGENE™ 6 (Roche, Castle Hill, NSW, Australia), prepared according to manufacturer's instruction, were used per dish. Multiple plates were used to transfect a complete representation of the cDNA library (10 6 cDNA clones). FACS was performed 72 h after transfection, and the cells were harvested, transferred into FACS tubes (BD, Franklin Lakes, NJ, USA), and washed once with phosphatebuffered saline (PBS; calcium-and magnesium-free PBS used throughout; Gibco, Melbourne, VIC, Australia). The cells were passed twice through a 25-G needle (BD), counted, and resuspended at 10 5 Immunolabeled cells were collected in 1% BSA-PBS, and episomal DNA was extracted using Puregene ® kit (Gentra Systems, Minneapolis, MN, USA). The cells were then pelleted at 10,000× g for 3 min and resuspended in the residual 30 µL solution (from the Puregene kit). Three hundred microliters cell lysis solution (from the Puregene kit) were added to the cell pellet and pipeted up and down to lyse and homogenize the cells. Thirty micrograms proteinase K were added to the cell lysate, mixed by inversion, and incubated overnight at 55°C. Six micrograms RNase were added to the cell lysate and incubated at 37°C for 1 h. The sample was cooled to room temperature, and 100 µL protein precipitation solution (from the Puregene kit) were added to the RNAase-treated cell lysate, vortex mixed, incubated on ice for 5 min, and centrifuged at 10,000× g for 5 min. The supernatant containing the DNA was transferred into a clean microfuge tube, precipitated using 20 µg glycogen (Roche) and 300 µL 100% isopropanol. The sample was mixed gently by inverting the tube several times and then incubated on ice for 15 min. The sample was centrifuged at 10,000× g for 20 min at 4°C. The pellet was washed with 70% ethanol, air-dried, and resuspended in 20-30 µL Tris-EDTA (TE) solution. The episomal DNA was electroporated using the Gene Pulser ® system (Bio-Rad Laboratories, Hercules, CA, USA) set at 200 ohms, 25 µF, and 2.2 kV, into electrocompetent XLIB cells and plated on kanamycin agar plates.
The histogram in Figure 1 depicts multiparameter detection by FACS. The x-and y-axes show the fluorescent intensity of fluorescein 5′-isothiocyanate (FITC) and PE stain (compensated for autofluorescence and endogenous c-erbB2 expression), and gates were set to sort cells (depicted in thick black box). Figure 1A shows 0.13% of the cells in the gated region for the isotype control. For round 1 of cDNA library screening, 0.24% of the total cells were collected in the gated region ( Figure 1B , total of 6000 cells). To increase the probability of capturing a stained cell, sorting was done in an enrichment mode. This mode enables collection of target cells regardless of the presence of coincident nontarget events (13) . Episomal DNA was extracted from these cells, and it was electroporated into electrocompetent XLIB cells. All the bacterial colonies were pooled, and large-scale plasmid DNA was extracted. This DNA was transfected into Cos7 cells and immunolabeled for a second round of sorting on FACS. The sort showed an approximately 10-fold enrichment for the c-erbB2 clones ( Figure 1C) . Sorting decisions were similar to that in round 1, except that cells were sorted in a recovery mode. This mode enabled exclusion of target cells coincident with nontarget cells, thus resulting in a higher purity of sorted cells. The gated region contained 1.9% of the brightest cells, and 12,000 cells were collected. Episomal DNA was extracted, electroporated into XLIB cells, and individual clones were screened. Two out of 25 clones screened showed 2.2% of immunolabeled cells ( Figure  1D ). Sequence analysis revealed high homology to the c-erbB2 sequence [P(N) = 5 × 10 -20 ]. However, the insert encoded a partial c-erbB2 sequence from the C terminus (2200 bp). The FACS signal from these clones is low, probably due to a low expression level of the gene of interest, or alternately, the transient overexpression of the insert may be toxic to cells. The enrichment of the clone can be improved by using biotinylated probes.
The above methodology isolates clones encoding the cytoplasmic domain of c-erbB2 protein from a cDNA library using high-speed cell sorting. Despite the intracellular localization of c-erbB2 protein and low endogenous levels in Cos7 cells, a definite enrichment of the clone of interest was seen while sorting from round 1 to round 2. This is an improvement over the existing methods, in which the isolation of the clones was restricted to cell surface antigens or required a vector that contains a signal sequence to target all cDNA clones to the membrane. Although this technique is limited by transiently transfected cell system and availability of purified antibody or probe, it can be used to isolate novel intracellular proteins and study regulators of endogenous genes. 
